Furthermore, our study did not evaluate the potential contribution of other immune cell populations in the tumor microenvironment, such as T cells, B cells, or myeloid-derived suppressor cells, which may interact with NK cells and influence the immunological role of HMGB2. Here, HMGB2 is linked to neoplasm.